Table 5.
Disorders | Total sample | Sex-limitation | |||||||
---|---|---|---|---|---|---|---|---|---|
| |||||||||
Female | Male | ||||||||
| |||||||||
A | C | E | A | C | E | A | C | E | |
IHS MO/MA | 0.53 (0.35–0.72) | 0.29 (0.13–0.44) | 0.18 (0.13–0.24) | 0.60 (0.39–0.80) | 0.23 (0.054–0.41) | 0.16 (0.11–0.23) | 0.32 (0.040–0.70) | 0.36 (0.056–0.62) | 0.32 (0.19–0.48) |
MDD | 0.52 (0.44–0.59) | – | 0.48 (0.41–0.56) | 0.56 (0.46–0.65) | – | 0.44 (0.35–0.50) | 0.42 (0.27–0.56) | – | 0.58 (0.44–0.73) |
Bivariate variance | 0.13 (0.070–0.25) | – | 2.0×10−4 (8.6×10−11–0.018) | 0.094 (0.038–0.20) | – | 0.016 (5.7×10−7–0.074) | 0.13 (0.020–0.52) | – | 0.047 (1.6×10−6–0.18) |
Correlation | 0.51 (0.37–0.69) | – | −0.020 (−0.19–0.15) | 0.41 (0.26–0.60) | – | −0.19 (−0.41–0.036) | 0.56 (0.19–1) | – | 0.29 (−8.5×10−4–0.56) |
A: additive genetic factors; C: non-unique environmental factors E: unique environmental factors.